Skip to Content
Regeneron Pharmaceuticals Inc. Logo.

Investors & Media

About Regeneron

Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases.

Learn more about Regeneron 
Download our corporate fact sheet 
REGN October 2026 Corporate Presentation
Download our investor presentation

Press releases

Nov 02
Regeneron Announces Investor Conference Presentations
Oct 30
Regeneron Reports Third Quarter 2026 Financial and Operating Results
Oct 26
Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparedness
Visit our newsroom

Upcoming & recent events

Nov 10, 2026 8:30 AM EST

CIDEB MASH Roundtable

Listen to webcast
View event details
View investor events

Quarterly materials

Show all

Market Cap:

Nov 2, 2026 5:34 PM EST

Minimum 15 minutes delayed. Source: LSEG

Interactive analyst center

Interactive and downloadable financial data for investors and analysts.

View analyst center

Annual materials

2025 Year In Review
Visit: 2025 Year in Review
2026 Proxy Statement
2026 Proxy Statement
2025 Responsibility Report
2025 Responsibility Report

Corporate responsibility

We're dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations.

Our TCFD (Task Force on Climate-related Financial Disclosures) Report, previously published as a standalone report, is now included in the appendix of our annual Responsibility Report.

Learn about our approach to corporate responsibility 

2025 Regeneron Responsibility Report.
Download our annual Responsibility Report
2025 Regeneron Task Force on Climate-related Financial Disclosures (TCFD) Report.
Download our annual TCFD Report

Contact us

Investors

914.847.7741

invest@regeneron.com

Media

media@regeneron.com

Sign up for email alerts
Regeneron corporate and R&D headquarters
Back to top